pharmacie et médicaments – Plafonnement des remises sur les médicaments génériques

This written question concerns the capping of rebates on generic medicines in France. It seeks clarification on the current regulations and potential impacts on the pharmaceutical market. The question affects pharmaceutical companies, pharmacies, and potentially patients by influencing the cost and availability of generic drugs.